Triple
T17377864
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Cambridge Antibody Technology |
E422486
|
entity |
| Predicate | successorOrganization |
P78
|
FINISHED |
| Object | AstraZeneca biologics division |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: AstraZeneca biologics division | Statement: [Cambridge Antibody Technology, successorOrganization, AstraZeneca biologics division]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: AstraZeneca biologics division Context triple: [Cambridge Antibody Technology, successorOrganization, AstraZeneca biologics division]
-
A.
AstraZeneca
chosen
AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
-
B.
AstraZeneca global corporate headquarters
AstraZeneca global corporate headquarters is the central administrative and research hub of the multinational pharmaceutical company AstraZeneca, located on the Cambridge Biomedical Campus in Cambridge, UK.
-
C.
Boehringer Ingelheim
Boehringer Ingelheim is a major German research-driven pharmaceutical company known for developing prescription medicines, animal health products, and biopharmaceuticals worldwide.
-
D.
Merck Life Science
Merck Life Science is the life science business of Merck KGaA, providing products and technologies for research, biotechnology, and pharmaceutical development worldwide.
-
E.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d889d6535c81908be333c01deaec4e |
completed | April 10, 2026, 5:25 a.m. |
| NER | Named-entity recognition | batch_69e43a6ea56c8190b56d966ccf2c91f7 |
completed | April 19, 2026, 2:14 a.m. |
Created at: April 10, 2026, 5:45 a.m.